​

Funding Round

Series A - Tallac Therapeutics

Series A - Tallac Therapeutics

Investment Firm

Overview

Tallac Therapeutics offers next generation immunotherapies for cancer patients.

Announced Date

Dec 01, 2020

Closed on Date

Dec 01, 2020

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorMorningside Venture Investments
Participant InvestorMRL Ventures Fund
Participant InvestorvenBio Partners
Participant InvestorLightstone Ventures
Participant InvestorMatrix Partners China

Round Details and Background

Tallac Therapeutics raised $62000000 on 2020-12-01 in Series A

Tallac Therapeutics offers next generation immunotherapies for cancer patients.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 23, 2020
Venture Round - Tallac Therapeutics
-21.2M
Dec 01, 2020
Series A - Tallac Therapeutics
5-62.0M
Aug 02, 2023
Debt Financing - Tallac Therapeutics
1-5.0M

Recent Activity

There is no recent news or activity for this profile.